Jeil Pharmaceutical Co.,Ltd
KRX:271980.KS
15180 (KRW) • At close October 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 173,178.876 | 170,415.791 | 179,668.047 | 177,205.642 | 178,469.774 | 191,050.295 | 171,442.577 | 176,116.651 | 194,671.252 | 179,999.444 | 173,021.524 | 181,704.649 | 175,508.831 | 170,458.225 | 172,896.958 | 173,251.063 | 174,339.294 | 170,837.522 | 167,245.692 | 166,946.58 | 170,816.232 | 166,398.371 | 164,461.686 | 160,207.204 | 153,365.836 | 149,040.032 | 159,330.47 | 159,300.625 | 52,960.668 |
| Cost of Revenue
| 129,330.965 | 128,699.937 | 135,607.661 | 136,964.39 | 136,743.412 | 133,004.977 | 134,718.884 | 138,070.327 | 152,640.765 | 140,001.789 | 135,217.157 | 142,639.386 | 135,286.309 | 131,573.989 | 131,808.231 | 134,724.635 | 135,649.982 | 132,450.822 | 129,918.306 | 126,805.833 | 131,478.116 | 131,280.971 | 126,397.193 | 125,979.19 | 118,906.33 | 117,159.976 | 124,993.636 | 127,194.863 | 42,363.996 |
| Gross Profit
| 43,847.911 | 41,715.854 | 44,060.387 | 40,241.252 | 41,726.362 | 58,045.318 | 36,723.693 | 38,046.324 | 42,030.487 | 39,997.655 | 37,804.367 | 39,065.263 | 40,222.522 | 38,884.237 | 41,088.726 | 38,526.428 | 38,689.312 | 38,386.699 | 37,327.386 | 40,140.747 | 39,338.116 | 35,117.4 | 38,064.493 | 34,228.014 | 34,459.506 | 31,880.056 | 34,336.833 | 32,105.762 | 10,596.672 |
| Gross Profit Ratio
| 0.253 | 0.245 | 0.245 | 0.227 | 0.234 | 0.304 | 0.214 | 0.216 | 0.216 | 0.222 | 0.218 | 0.215 | 0.229 | 0.228 | 0.238 | 0.222 | 0.222 | 0.225 | 0.223 | 0.24 | 0.23 | 0.211 | 0.231 | 0.214 | 0.225 | 0.214 | 0.216 | 0.202 | 0.2 |
| Reseach & Development Expenses
| 10,649.806 | 10,700.194 | 12,145.233 | 10,631.834 | 12,912.926 | 10,037.396 | 9,246.246 | 8,669.254 | 11,193.879 | 12,038.061 | 9,055.527 | 12,550.327 | 8,284.337 | 9,083.558 | 6,984.927 | 6,865.45 | 5,466.642 | 4,953.178 | 7,376.375 | 4,816.963 | 4,502.788 | 5,417.75 | 6,212.818 | 5,765.496 | 6,936.458 | 5,960.88 | 5,213.205 | 0 | 2,318.533 |
| General & Administrative Expenses
| 60,552.627 | 44,602.882 | 8,495.2 | 8,169.761 | 8,502.954 | 8,335.197 | 8,880.75 | 7,538.794 | 7,816.599 | 6,530.865 | 6,654.529 | 6,465.903 | 6,423.708 | 6,240.259 | 6,190.399 | 5,767.31 | 5,849.83 | 4,577.523 | 1,296.008 | 9,349.26 | 8,204.98 | 6,304.459 | 1,271.244 | 5,892.37 | 6,327.83 | 5,767.282 | 3,503.274 | 30,044.617 | 1,821.156 |
| Selling & Marketing Expenses
| -31,471.958 | -11,463.893 | 10,650.455 | 10,725.031 | 10,907.614 | 10,695.345 | 10,220.308 | 11,132.903 | 11,418.886 | 11,093.661 | 12,930.137 | 10,239.37 | 14,330.224 | 11,871.125 | 12,487.677 | 12,799.942 | 10,965.431 | 11,748.003 | 14,797.219 | 11,205.333 | 10,428.401 | 9,572.102 | 12,509.264 | 8,907.695 | 9,064.163 | 8,039.737 | 8,443.295 | 0 | 2,202.06 |
| SG&A
| 29,080.669 | 33,138.989 | 33,239.171 | 18,894.792 | 19,410.568 | 19,030.542 | 19,101.058 | 18,671.697 | 19,235.485 | 17,624.526 | 19,584.666 | 16,705.273 | 20,753.932 | 18,111.384 | 18,678.076 | 18,567.252 | 16,815.261 | 16,325.526 | 16,093.227 | 20,554.593 | 18,633.381 | 15,876.561 | 13,780.508 | 14,800.065 | 15,391.993 | 13,807.019 | 11,946.569 | 30,044.617 | 4,023.216 |
| Other Expenses
| -19,264.347 | -151.456 | -148.379 | -552.365 | 209.151 | 12,806.387 | 13,355.288 | 13,484.666 | 13,870.977 | 13,811.356 | 634.204 | 2,327.916 | -464.301 | 266.809 | 203.499 | 78.519 | 236.542 | 83.959 | 158.114 | 415.607 | 100.407 | 14.636 | -11.186 | 31.803 | 208.51 | 467.651 | 56.703 | 47.12 | 136.524 |
| Operating Expenses
| 58,994.822 | 43,990.639 | 45,532.783 | 42,837.166 | 44,941.096 | 41,874.325 | 41,702.592 | 40,825.617 | 44,300.341 | 43,473.943 | 44,068.737 | 41,434.121 | 41,177.693 | 39,525.499 | 39,084.862 | 37,337.358 | 34,246.034 | 33,118.539 | 46,107.149 | 37,574.189 | 34,830.208 | 33,036.993 | 33,911.319 | 32,447.792 | 33,732.466 | 31,150.418 | 31,823.914 | 30,044.617 | 10,204.651 |
| Operating Income
| -15,146.911 | -2,274.785 | -1,472.396 | -2,652.484 | -3,214.734 | 16,170.993 | -4,978.899 | -2,779.293 | -2,192.615 | -3,476.288 | -6,264.37 | -2,519.103 | -955.17 | -791.508 | 2,003.864 | 1,189.07 | 4,443.278 | 5,268.161 | -8,779.763 | 2,566.558 | 4,507.908 | 2,080.407 | 4,153.174 | 1,780.222 | 727.04 | 729.639 | 2,512.919 | 2,061.145 | 392.021 |
| Operating Income Ratio
| -0.087 | -0.013 | -0.008 | -0.015 | -0.018 | 0.085 | -0.029 | -0.016 | -0.011 | -0.019 | -0.036 | -0.014 | -0.005 | -0.005 | 0.012 | 0.007 | 0.025 | 0.031 | -0.052 | 0.015 | 0.026 | 0.013 | 0.025 | 0.011 | 0.005 | 0.005 | 0.016 | 0.013 | 0.007 |
| Total Other Income Expenses Net
| -7,669.176 | -660.36 | -5,421.954 | -1,856.042 | 1,996.49 | -1,620.153 | 1,097.131 | -1,055.141 | 657.864 | -519.404 | -3,826.746 | 2,121.475 | 3,837.396 | -748.176 | -57.06 | -114.688 | -593.931 | 413.295 | -1,258.85 | 265.636 | -36.687 | -216.491 | -2,415.766 | -418.17 | 40.37 | 291.94 | -1,352.397 | -453.273 | 162.869 |
| Income Before Tax
| -22,816.087 | -2,935.145 | -6,894.351 | -4,508.526 | -1,218.244 | 14,550.839 | -3,881.768 | -3,834.435 | -1,534.751 | -3,995.692 | -15,079.376 | -247.383 | 2,882.225 | -1,389.438 | 1,946.805 | 1,074.382 | 3,849.347 | 5,681.455 | -10,038.613 | 2,832.193 | 4,471.221 | 1,863.916 | 1,737.408 | 1,362.052 | 767.41 | 1,021.578 | 1,160.522 | 1,607.872 | 554.89 |
| Income Before Tax Ratio
| -0.132 | -0.017 | -0.038 | -0.025 | -0.007 | 0.076 | -0.023 | -0.022 | -0.008 | -0.022 | -0.087 | -0.001 | 0.016 | -0.008 | 0.011 | 0.006 | 0.022 | 0.033 | -0.06 | 0.017 | 0.026 | 0.011 | 0.011 | 0.009 | 0.005 | 0.007 | 0.007 | 0.01 | 0.01 |
| Income Tax Expense
| 4,746.207 | 339.586 | -3,964.781 | 116.702 | 536.181 | 27.421 | 317.488 | 554.737 | 438.335 | 451.809 | -1,357.229 | 547.388 | 1,555.367 | 406.12 | 1,617.221 | 649.978 | 1,457.788 | 1,862.2 | 4,030.444 | 1,623.452 | 2,470.67 | 1,519.17 | 912.199 | 828.892 | 580.369 | 677.955 | 800.065 | 1,116.309 | 339.316 |
| Net Income
| -26,512.773 | -2,877.846 | -2,237.145 | -4,111.136 | -1,349.501 | 12,702.526 | -4,199.256 | -4,389.171 | -1,973.086 | -4,447.5 | -11,069.878 | -355.168 | 267.397 | -1,315.628 | 275.384 | 429.923 | 2,391.559 | 3,819.255 | -14,069.057 | 1,103.893 | 1,930.004 | 344.746 | 825.209 | 533.16 | 187.041 | 343.623 | 360.458 | 491.564 | 215.574 |
| Net Income Ratio
| -0.153 | -0.017 | -0.012 | -0.023 | -0.008 | 0.066 | -0.024 | -0.025 | -0.01 | -0.025 | -0.064 | -0.002 | 0.002 | -0.008 | 0.002 | 0.002 | 0.014 | 0.022 | -0.084 | 0.007 | 0.011 | 0.002 | 0.005 | 0.003 | 0.001 | 0.002 | 0.002 | 0.003 | 0.004 |
| EPS
| -1,819.49 | -197.5 | -153.53 | -282.14 | -92.61 | 871.74 | -287.92 | -301.12 | -135.56 | -305.12 | -759.95 | -24.31 | 18 | -90.05 | 18.84 | 29 | 164 | 260 | -963.02 | 75 | 131 | 23 | 56.14 | 36 | 13 | 23.57 | 24.52 | 33.57 | 15 |
| EPS Diluted
| -1,819.49 | -197.5 | -153.53 | -282.14 | -92.61 | 871.74 | -287.92 | -301.08 | -135.35 | -304.94 | -748.03 | -24 | 18 | -90 | 18.84 | 29 | 164 | 260 | -959.2 | 75 | 131 | 23 | 56.14 | 36 | 13 | 23.57 | 24.52 | 33.57 | 15 |
| EBITDA
| -12,243.317 | 398.846 | 1,118.058 | -490.158 | 568.311 | 18,644.966 | -2,632.625 | -780.083 | 8.806 | -1,309.37 | -3,454.003 | 2,328.848 | 3,508.419 | 1,113.669 | 4,446.362 | 3,602.818 | 4,592.692 | 8,182.093 | -6,936.371 | 5,009.179 | 6,636.423 | 4,028.396 | 3,989.402 | 3,313.357 | 2,630.905 | 3,086.089 | 1,573.886 | 2,061.145 | 677.174 |
| EBITDA Ratio
| -0.071 | 0.002 | 0.006 | -0.003 | 0.003 | 0.098 | -0.015 | -0.004 | 0 | -0.007 | -0.02 | 0.013 | 0.02 | 0.007 | 0.026 | 0.021 | 0.026 | 0.048 | -0.041 | 0.03 | 0.039 | 0.024 | 0.024 | 0.021 | 0.017 | 0.021 | 0.01 | 0.013 | 0.013 |